Clinical Trial: Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07471230) titled 'Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism' on March 10.

Brief Summary: This clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism.

The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments targeting neurodegeneration within dopaminergic pathways.

Study Start Date: Nov. 23, 2026

Study Type: INTERVENTIONAL

Condition: Parkinsonism or Parkinson's Disease Nos Parkinsonism in Diseases Classified ...